Research programme: topical antiviral treatments - RxKinetix
Latest Information Update: 05 Dec 2006
At a glance
- Originator RxKinetix
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Viral infections
Most Recent Events
- 28 Jun 2002 Preclinical trials in Viral infections in USA (Topical)